# Drais Pharmaceuticals Inc: Form D filing

Drais Pharmaceuticals Inc, a biotechnology company in Bridgewater, NJ, filed a Form D with the SEC in 2010. The latest, on February 22, 2010, reports $20 million sold of an offering with no set size to 31 investors.

Find out what Drais Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Drais%20Pharmaceuticals%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Drais%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fdrais-pharmaceuticals-inc-1422847)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Drais%20Pharmaceuticals%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Drais%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fdrais-pharmaceuticals-inc-1422847)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 520 US Highway 22, Suite 201, Bridgewater, NJ, 08807
- Phone: (908) 895-1200
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2007
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1422847

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 22, 2010 | Amendment | Indefinite | $20,000,000 | Indefinite | 31 | Dec 14, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1422847/000142284710000002/0001422847-10-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jeff Bird | Director |  |
| Robert Desjardins | Executive Officer, Director |  |
| Donna Tempel | Executive Officer, Director |  |
| Arnold Oronsky | Executive Officer |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Feb 22, 2010](https://specstream.ai/data/form-d/week/2010-02-22) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Drais Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).